chr4-83319694-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001098540.3(HPSE):c.374-225A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.795 in 152,052 control chromosomes in the GnomAD database, including 48,241 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.80 ( 48241 hom., cov: 30)
Consequence
HPSE
NM_001098540.3 intron
NM_001098540.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.0350
Publications
8 publications found
Genes affected
HPSE (HGNC:5164): (heparanase) Heparan sulfate proteoglycans are major components of the basement membrane and extracellular matrix. The protein encoded by this gene is an enzyme that cleaves heparan sulfate proteoglycans to permit cell movement through remodeling of the extracellular matrix. In addition, this cleavage can release bioactive molecules from the extracellular matrix. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.851 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| HPSE | NM_001098540.3 | c.374-225A>G | intron_variant | Intron 2 of 11 | ENST00000311412.10 | NP_001092010.1 | ||
| HPSE | NM_006665.6 | c.374-225A>G | intron_variant | Intron 3 of 12 | NP_006656.2 | |||
| HPSE | NM_001199830.1 | c.374-225A>G | intron_variant | Intron 2 of 10 | NP_001186759.1 | |||
| HPSE | NM_001166498.3 | c.374-225A>G | intron_variant | Intron 3 of 10 | NP_001159970.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.795 AC: 120847AN: 151934Hom.: 48206 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
120847
AN:
151934
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.795 AC: 120935AN: 152052Hom.: 48241 Cov.: 30 AF XY: 0.794 AC XY: 58988AN XY: 74318 show subpopulations
GnomAD4 genome
AF:
AC:
120935
AN:
152052
Hom.:
Cov.:
30
AF XY:
AC XY:
58988
AN XY:
74318
show subpopulations
African (AFR)
AF:
AC:
35201
AN:
41476
American (AMR)
AF:
AC:
11322
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
AC:
2761
AN:
3468
East Asian (EAS)
AF:
AC:
4511
AN:
5172
South Asian (SAS)
AF:
AC:
3899
AN:
4814
European-Finnish (FIN)
AF:
AC:
8026
AN:
10566
Middle Eastern (MID)
AF:
AC:
221
AN:
294
European-Non Finnish (NFE)
AF:
AC:
52786
AN:
67974
Other (OTH)
AF:
AC:
1650
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1260
2520
3780
5040
6300
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
870
1740
2610
3480
4350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2952
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.